Jinhai Medical Technology Limited (2225.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.08B |
| Enterprise Value | 1.06B |
| P/E Ratio | -237.21 |
| PEG Ratio | 48.24 |
| Price/Sales Ratio | 89.48 |
| Price/Book Ratio | 80.34 |
| Enterprise/Revenue | 89.04 |
| Enterprise/EBITDA | -291.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.37 |
| Operating Margin | -0.41 |
AD
Management Effectiveness
| Return On Assets | -0.19 |
| Return On Equity | -0.43 |
Income Statement
| Revenue | 46.28M |
| Revenue/Share | 0.01 |
| Gross Profit | 7.19M |
| EBITDA | -14.39M |
| Net Income | -17.08M |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 36.78M |
| Total Cash/Share | 0.01 |
| Total Debt | 14.91M |
| Total Debt/Equity | 0.29 |
| Current Ratio | 1.84 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | 496.91 |
| 52-Week High | 5.4 |
| 52-Week Low | 0.48 |
| Moving Average 50 Days | 3.92 |
| Moving Average 200 Days | 2.69 |
Statistics
| Average Volume | 9.68M |
| Shares Outstanding | 5.29B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | December 12, 2024 |
AD
